These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 31768221)

  • 21. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
    Hryhorowicz M; Lipiński D; Zeyland J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.
    Cai B; Sun S; Li Z; Zhang X; Ke Y; Yang J; Li X
    Hum Genet; 2018 Sep; 137(9):679-688. PubMed ID: 30203114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.
    Shojaei Baghini S; Gardanova ZR; Abadi SAH; Zaman BA; İlhan A; Shomali N; Adili A; Moghaddar R; Yaseri AF
    Cell Mol Biol Lett; 2022 May; 27(1):35. PubMed ID: 35508982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
    Zhang D; Zhang Z; Unver T; Zhang B
    J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of CRISPR/Cas9 technology in sepsis research.
    Wu M; Hu N; Du X; Wei J
    Brief Funct Genomics; 2020 May; 19(3):229-234. PubMed ID: 32058568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-Cas9 Genome Engineering: Trends in Medicine and Health.
    Zaib S; Saleem MA; Khan I
    Mini Rev Med Chem; 2022; 22(3):410-421. PubMed ID: 34517795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Editing in Clinical Practice: Where are We?
    Mittal RD
    Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR/Cas based gene editing: marking a new era in medical science.
    Prasad K; George A; Ravi NS; Mohankumar KM
    Mol Biol Rep; 2021 May; 48(5):4879-4895. PubMed ID: 34143395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment.
    Liu B; Saber A; Haisma HJ
    Drug Discov Today; 2019 Apr; 24(4):955-970. PubMed ID: 30849442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas gene-editing technology and its advances in dentistry.
    Chavez-Granados PA; Manisekaran R; Acosta-Torres LS; Garcia-Contreras R
    Biochimie; 2022 Mar; 194():96-107. PubMed ID: 34974144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9 in Stem Cell Research: Current Application and Future Perspective.
    Patmanathan SN; Gnanasegaran N; Lim MN; Husaini R; Fakiruddin KS; Zakaria Z
    Curr Stem Cell Res Ther; 2018; 13(8):632-644. PubMed ID: 29895256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
    Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
    Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome editing using CRISPR, CAST, and Fanzor systems.
    Song B; Bae S
    Mol Cells; 2024 Jul; 47(7):100086. PubMed ID: 38909984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.